ProFem GmbH
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC) (NCT04734405) | ProFem GmbH | 2019-10-01 |
Track ProFem GmbH automatically
Every clearance here is in the API, with alerts when new ones post.